0001104659-13-080067.txt : 20131101 0001104659-13-080067.hdr.sgml : 20131101 20131101161308 ACCESSION NUMBER: 0001104659-13-080067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131031 FILED AS OF DATE: 20131101 DATE AS OF CHANGE: 20131101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED INC CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 DEER PARK DRIVE STREET 2: SUITE C CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 BUSINESS PHONE: 732-997-4600 MAIL ADDRESS: STREET 1: 9 DEER PARK DRIVE STREET 2: SUITE C CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewis William CENTRAL INDEX KEY: 0001402051 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 131186063 MAIL ADDRESS: STREET 1: C/O AEGERION PHARMACEUTICALS, INC. STREET 2: 1140 ROUTE 22 EAST, SUITE 304 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 4 1 a4.xml 4 X0306 4 2013-10-31 0 0001104506 INSMED INC INSM 0001402051 Lewis William C/O INSMED INC 9 DEER PARK DRIVE, SUITE C MONMOUTH JUNCTION NJ 08852 1 1 0 0 President and CEO Common Stock 2013-11-01 4 P 0 5233 14.28 A 46972 D Stock Option-Right to Buy 3.40 2013-09-10 2022-09-10 Common Stock 708314 708314 D Stock Option-Right to Buy 4.55 2013-09-28 2022-09-28 Common Stock 186170 186170 D Stock Option-Right to Buy 12.44 2014-05-23 2023-05-23 Common Stock 83333 83333 D Stock Option-Right to Buy 12.44 2023-05-23 Common Stock 166667 166667 D Stock Option-Right to Buy 14.24 2014-10-31 2013-10-31 Common Stock 250000 250000 D Open market purchase pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.15 to $14.46, inclusive. The reporting person undertakes to provide to Insmed Incorporated, any security holder of Insmed Incorporated or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. These options become exercisable with respect to 25% of the shares of common stock subject to this grant on September 10, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of September 10, 2013 thereafter through September 10, 2016. These options become exercisable with respect to 25% of the shares of common stock subject to this grant on September 28, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of September 28, 2013 thereafter through September 28, 2016. These options become exercisable with respect to 25% of the shares of common stock subject to this grant on May 23, 2014, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of May 23, 2014 thereafter through May 23, 2017. These options become exercisable upon the achievement of certain performance criteria. These options become exercisable with respect to 25% of the shares of common stock subject to this grant on October 31, 2014, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of October 31, 2014 thereafter through October 31, 2017. /s/ Christine Pellizzari, as attorney-in-fact for William Lewis 2013-11-01